Martha Parra Ankylosing Spondylitis
Ankylosing Spondylitis — Clinical Case: Successful Treatment with CDS Protocol
Case Summary
Female patient diagnosed with ankylosing spondylitis in 2020, presenting with complete immobility due to severe pain (100/100) and inflammation throughout the entire body. Ankles were severely swollen, body felt rigid. After consistent CDS treatment, the disease was completely resolved as confirmed by medical imaging. Patient now reports no disease for over 11 medical controls.
Clinical History
Event date: 2020 (diagnosis) to 2024 (confirmed resolution)
Geographic context: Colombia
Prior medical situation: Patient diagnosed with ankylosing spondylitis, classified as "incurable" by conventional medicine. Patient was unable to walk due to severe pain and inflammation. Ankles were severely swollen. Body felt completely rigid.
Treatment Applied
Patient initiated Protocol C (CDS oral prophylaxis) starting from the ultrasound examination date. Treatment continued for 70 days until the next medical control. The ultrasound examination demonstrated complete resolution of the disease previously classified as "incurable."
Patient rested for 5 days and then resumed Protocol C for another 84 days until the next control. The study again showed clean results.
As of May 2024, patient reports 11 consecutive medical controls with no evidence of disease.
Treatment Protocol
Protocol C: CDS oral drops administered consistently over a period of 70 days, followed by a 5-day rest period, then continued for an additional 84 days.
Recommended protocol for this condition: Protocol C10 to C30. During acute dysmenorrhea symptoms, initiate Protocol F10 to F20 followed by Protocol C20 to C30 for the remainder of the day. Add Protocol V twice daily and perform Protocol E two to three times per week. Protocol Z with Biotrohn® or Plasmatrohn® may be integrated for more efficient evolution. Seawater intake for remineralization may be added.
Clinical Evolution
After 70 days of Protocol C: Ultrasound examination demonstrated complete disease resolution. Previously "incurable" condition had disappeared.
After additional 84 days of Protocol C: Second control study showed clean results.
Current status (May 2024): 11 consecutive medical controls with no disease evidence. Patient states: "INCURABLE WAS YESTERDAY."
Laboratory Data
Medical laboratory values showed significant improvement in inflammatory markers during CDS treatment: - PCR decreased from 29.67 mg/L to 10.79 mg/L (2021) - ESR decreased from 64.00 mm/hour to 27.0 mm/hour (2021) - By 2022: PCR descended to 4.25 mg/L (normal reference range), ESR at 25 mm/hour - HLA-B27 positive for spondyloarthritis
Testimony Original
Patient (Martha Parra): "I was diagnosed with ankylosing spondylitis in the year 2020 and I reached the state of being unable to move; I could not walk because the pain and inflammation were too strong, 100/100 throughout my entire body. My ankles were not visible from how swollen they were; I could not move because my body felt rigid. It was terrible. I started taking a Protocol C from that ultrasound until the next control, a total of 70 exact days. Upon performing the study, it was demonstrated that the disease catalogued as 'incurable' no longer existed. I rested 5 days and started Protocol C again until the next control (about 84 days), and again, the study came out clean. Today, May 2024, I share my testimony, telling you that I already have 11 controls from that moment and there is no disease. 'INCURABLE WAS YESTERDAY.'"
Sources
- Direct testimony from the patient - Publication authorization by Dr. Kalcker and the patient
See also
- - - -